Fox Jennifer Lynne 4
4 · Emergent BioSolutions Inc. · Filed Dec 13, 2022
Insider Transaction Report
Form 4
Fox Jennifer Lynne
EVP, Ext Aff, GC, Corp Sec
Transactions
- Award
Common Stock
2022-12-09+14,045→ 46,256 total - Award
Common Stock
2022-12-09+42,135→ 88,391 total
Footnotes (2)
- [F1]Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period. The amount reported is based on the target performance payout factor, or 100%.
- [F2]Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in one annual installment beginning on the day prior to the second anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement.